William Lasher

@uTobian @WhiteHouse @ferrisbuhler81 And @alextatem what do you think? Particularly concerning compounded GLP-1s?

@uTobian @WhiteHouse @ferrisbuhler81 what do you think about these departures?

The @WhiteHouse fired Marty Makary, Tracy Beth Høeg, and Katherine Szarama at FDA to clear the path for the approval of the junk science Moderna mRNA flu shot favored by Republican megadonor Stephen Schwarzman. It's the most extreme case of regulatory capture in history.

@KVanthof @RedWavePress @joerogan @joerogan you absolutely should have @KVanthof on your show

@RedWavePress @joerogan give the people that work in this vitally important US based industry a chance to explain

Joe Rogan: “I talked to Tim Dillon today… He told me that gas is $7.90 a gallon in LA right now.” Brendan Schaub: “And that's down from what it was. I was out there a month shooting a commercial and it was up to $8.40 something.” Joe Rogan: “Here's what I don't understand. Are we getting oil from Iran?... So are they just f*cking us in the a$$?” “Or is it global prices went up because some of the gas can’t get to where it needs to go, and so they need to make that money so they just f*ck you. Isn’t it funny? They’re like, we’re going to make money no matter what. The American people are going to lose money so we make the same amount of money. F*ck you, you need oil.” “[Oil executives are] a bunch of crooks. We should have a national oil company and only sell in America. Keep it in house so no matter what foul sh*t we do outside the in the world [prices don’t go up].” “Even though U.S. is the largest oil producer, companies can sell oil on the global market to whoever pays the highest price. High world prices still translate into high domestic gas prices.” “Hey, Mr. President, please fix that.”

@PeptideList I thought RFK said 2 weeks, several weeks ago? What are your thoughts?

We watched the entire 5-hour FDA meeting on peptides and supplements so you don't have to. The most interesting moment: they literally left "PEPTIDES" off their own slide because the word is "too controversial right now." Other things worth knowing: The industry openly stated the goal is to get peptides classified as dietary supplements, citing Kennedy's MAHA agenda by name. Scientists at the meeting warned that oral peptides "just get chewed up" in digestion meaning most supplement capsules won't work No decisions were made. This was listening mode. But the direction is clear: access is expanding, the timeline is 6-18 months. Nobody talked about who actually lists the providers selling these compounds right now. That's what we do. ThePeptideList.com

@TukiFromKL There will be universal income. Demand for goods do not go away with automation and ability to pay will only improve with more overall efficiency.

🚨 Bernie Sanders just said what everyone's thinking but nobody with money will say.. Jeff Bezos is worth $234 billion.. plans to replace 600,000 Amazon workers with robots.. and is raising $100 billion to buy factories and automate them.. he's not building jobs.. he's buying companies to delete them.. the same man whose workers pee in bottles because they can't take bathroom breaks is now spending $100 billion to make sure they don't need bathrooms at all.. and here's the question nobody's answering.. when 600,000 people lose their income.. who's buying from Amazon.. you can automate the workforce.. you can't automate the customer.

@himshouse @tbpn We need an inverse Cuban. Might crush inverse Cramer ETF.

🚨 BREAKING: MARK CUBAN ON PEPTIDES: "I'M NOT A BELIEVER IN THAT SH*T" @TBPN $HIMS $LLY $NVO

@ferrisbuhler81 @joerogan @ways2wellX @joeroganhq Thank you @ferrisbuhler81 for fighting for great healthcare and to @joerogan for support and providing a platform.

Great conversation with @joerogan thank you for having me on again. Back on the show talking peptides, broken healthcare, and why the future looks very different from the system we have today. The system manages sickness… the future creates health.

@BojanRadojici10 Would love the prompt please

Join my webinar: luma.com/xjj56tuc After 20 years in Excel, I finally watched an AI agent build a full model for me — end-to-end. I used Genspark and the result was insane: structure, schedules, cash flow, scenario switches… all generated, then refined with my assumptions. The biggest shift? I’m no longer stitching 20 sheets at 2 a.m. — I’m 𝗿𝗲𝘃𝗶𝗲𝘄𝗶𝗻𝗴, 𝘀𝘁𝗿𝗲𝘀𝘀-𝘁𝗲𝘀𝘁𝗶𝗻𝗴, 𝗮𝗻𝗱 𝗶𝗺𝗽𝗿𝗼𝘃𝗶𝗻𝗴 the model instead. If you want faster board-ready models: Start with a clear spec (drivers, outputs, constraints) Let AI draft the skeleton (P&L, BS, CF, links) You do the QA: tie-outs, edge cases, sensitivities Lock a repeatable prompt + data schema for next time If you want this Prompt, just drop a comment and I’ll send it to you. (Important: follow me so I can DM you!)

@alextatem @EliLillyandCo @novonordisk @EmpowerPharmacy @strivepharmacy @ADM_Christine @DrMakaryFDA @RobertKennedyJr @ferrisbuhler81 @BillAckman

How Big Pharma Weaponized the FDA to Kill Your Access to Personalized Medicine @EliLillyandCo @novonordisk @EmpowerPharmacy @strivepharmacy @ADM_Christine @DrMakaryFDA @RobertKennedyJr Compounding pharmacies are under attack — and millions of patients could lose access to affordable medications because of it. In this deep dive, Dr. Alex Tatem, board-certified urologist and men’s health specialist, breaks down the growing conflict between Big Pharma, the FDA, and compounding pharmacies that provide personalized medications like TRT, HCG, semaglutide, tirzepatide, and fertility treatments. Pharmaceutical companies such as Novo Nordisk and Eli Lilly are generating tens of billions from GLP-1 drugs like Ozempic, Wegovy, Mounjaro, and Zepbound. Meanwhile, compounding pharmacies have been producing lower-cost versions during nationwide drug shortages — sometimes for $100–$300 per month instead of $1,000+. Now lawsuits, legislation, and regulatory pressure threaten to shut that system down entirely. This video explains: • What compounding pharmacies are (503A vs 503B) • Why GLP-1 drugs like semaglutide and tirzepatide are at the center of the fight • The lawsuits filed by Novo Nordisk and Eli Lilly • The FDA’s biologics reclassification that banned compounded HCG • How drug shortages allowed compounding of semaglutide and tirzepatide • The proposed SAFE Drugs Act (H.R. 6509) • Indiana Senate Bill 282 and state-level restrictions • The economics behind the $100B GLP-1 drug market • Why personalized medicine and compounding pharmacies exist in the first place • The potential impact on TRT, fertility treatments, and weight-loss medications Dr. Tatem also outlines a policy solution that could expand patient access while maintaining safety oversight. If you care about drug pricing, medical freedom, fertility access, TRT, GLP-1 medications, or personalized medicine, this is a conversation that affects you. 👍 Like the video to help this reach more patients 💬 Comment your experience with compounded medications 📤 Share this video so policymakers and patients can hear the discussion 🔔 Subscribe for more science-based analysis on men’s health, pharmaceuticals, and medical policy #fda #glp1

@BojanRadojici10 Please send thank you!

Want to see how I built an LBO with Claude? Let’s be real! Can Claude handle full-scale financial modeling on its own? Of course not. But can it significantly help you? Absolutely. We are still at the very beginning, exploring the boundaries of what’s possible. From what I’ve seen so far, simple calculations and basic models work remarkably well. The complex stuff? That’s where it gets tricky. We are only at the beginning, I'm exploring the possibilities. For now, I see that simple calculations and models are done well, while more complex ones are somewhat more difficult. First, when I do models via Claude, I still need experience to create such prompts to get even better outputs. Also, I need experience and time to learn how to perform control of the models that Claude puts out. We are moving very fast on the AI path, so every week, we have something new. If someone hates Claude in Excel, they should ask the questions: Where were we a year ago with this, and Where could we be in 3 years? The gap is closing fast. Don’t get left behind. If you want this Prompt and Excel model, just drop a comment and I’ll send it to you. (Important: follow me so I can DM you!)

@sabir_huss50540 Send

🚨 Claude Opus 4.6 is insanely powerful. But 90% of people are using it like ChatGPT. That’s crazy. I’ve spent months testing it for: • Automation workflows • Agent building • Research • Content systems • Business ops And the difference between “basic prompts” and elite prompts is night and day. So I’m giving away my 500 Mega Prompts List for Claude Opus 4.6. These are the exact prompts I use to: → Automate repetitive tasks → Build AI agents → Generate high-leverage content → Analyze data like a consultant → Save 10+ hours per week No fluff. Just plug-and-play frameworks. If you want it: Comment “Send” I’ll DM it to you. 🔥

@Suryanshti777 Ai

STOP this is a $500 AI resource. I collected 700+ Claude mega prompts that can actually replace hours of real work. This pack normally sells for $500. But I’m giving it away for free. Follow me MUST (so i can dm you) Comment “AI” and I’ll send it to you.

@heynavtoor AI

Everyone is hyped about Claude… but barely anyone knows how to actually use it to replace real work. I collected 700+ mega prompts that turn Claude into a full-blown productivity engine. Comment "AI" and I’ll DM you everything.

@MarioNawfal woman was shoved by ICE / slipping on ice, then the suspect was trying to help her when ICE pepper sprayed both of them. The suspect fell to the ground. One of the ice agents removed suspect weapon and misfired the weapon, causing other ICE agent to fire and kill the suspect. Sad

🚨🇺🇸 BREAKING: FULL VIDEO SHOWS MINNEAPOLIS SHOOTING FROM CLEARER ANGLE Newly released footage captures the entire altercation from a closer vantage point, showing events leading up to the moment the suspect is shot. The video appears to show the suspect jumping onto the back of what may be another protester before being forcibly pulled off during the struggle. Moments later, shots are fired. Source: @KimKatieUSA

@elonmusk LFG @elonmusk !!

Let that sink in

@MZHemingway @Liz_Cheney @CommunityNotes

@Liz_Cheney Lying Liz, your propagandist cut it off before Trump said: “They're all war hawks when they're sitting in Washington in a nice building saying ‘Oh gee, let's send 10,000 troops into the mouths of the enemies.' She always wanted to go to war with people.”

This is how dictators destroy free nations. They threaten those who speak against them with death. We cannot entrust our country and our freedom to a petty, vindictive, cruel, unstable man who wants to be a tyrant. #Womenwillnotbesilenced #VoteKamala

@mcuban You’re a smart guy. I’m perplexed at your political position that I’m convinced you don’t even believe what you’re saying. 1 you’ve been offered something 2 they have something on you or 3 a bad personal issue with Trump you’re willing to sell out the country. Cleanse yourself.

Since your handle is “Whole Mars”, perhaps this lengthy reply is apropos: Getting the cost per ton to the surface of Mars low enough that humanity has the resources to make life multiplanetary requires a roughly 1000X improvement in rocket & spacecraft technology. Recent US Mars missions have had a cost per ton of useful load to the surface of Mars of about $1B. Moreover, it has become more, not less, expensive over time! To build a city on Mars that can grow by itself likely requires at least a million tons of equipment, which would therefore require >$1000 trillion, an obviously impossible number, given that US GDP is only $29T. However, if rocket technology can be improved by 1000X, then the cost of becoming sustainably multiplanetary would drop to ~$1T, which could be spread out over 40 or more years, so <$25B/year. At that cost, it becomes possible to make life multiplanetary, ensuring the long-term survival of life as we know it, without materially affecting people’s standard of living on Earth. Starship is designed to achieve a >1000X improvement over existing systems and, especially after yesterday’s booster catch and precise ocean landing of the ship, I am now convinced that it can work.

@OlmsteadJeffery @ClintSimmons33 @ericnuttall Wouldn’t it be a more proper comparison to show the chart net of SPR releases AND actual OPEC production cuts?

@ClintSimmons33 @ericnuttall Yes I would interpret it that way. The commercial stocks are growing at the expense of the SPR. Of note, the SPR release is about to complete sometime in Dec. It's half empty now, ~400m barrels left and these levels haven't been seen since the 80's. Not a good state.

There are times when the financial demand for oil implodes, despite the physical demand for oil, or at least inventory balances, remaining fine. This would appear to be such a time.